GRADUATE OF THE ROYAL COLLEGE OF SURGEONS RCSI,DUBLIN YEAR 2000.
KUWAITI BOARD IN NUCLEAR MEDICINE 2007 MASTERS IN NUCLEAR MEDICINE 2008 FROM KUWAIT UNIVERSITY .
WORKED IN MUBARAK ALKABEER GENERAL HOSPITAL FROM 2003-2007

WORKED IN AMIRI HOSPITAL 2007 -2013
WORKED IN SUBAH ALAHMED UROLOGY CENTER 2013 TILL 2016
CURRENTLY NUCLEAR MEDIINE CONSULTANT AT CHEST DISEASE HOSPITAL

Graduated from Kuwait university faculty of Medicine. Underwent post graduate training in Internal Medicine and Cardiology at McGill university, Montreal Canada. Advanced Fellowship training in adult CArdiac, electrophysiology and university of Texas in Houston, McGovern health sciences centre practising CArdiac electrophysiologist involved in the care of patients with inherited cardiac arrhythmias and infiltrative cardiomyopathy

MBBS, MSc (Nuclear Medicine), Ph.D. KBNM, With clinical Experience of more than 15 years in nuclear medicine and PET/CT and radionuclide therapy. I have 70 international publications with 10 experience in development of new radiopharmaceuticals, pre-clinical and clinical research. Main field of interest include molecular imaging, radionuclide therapy, image processing in PET CT using AI.

Dr Gopinath Gnanasegaran is a Consultant Nuclear Medicine Physician at the Royal Free London NHS Foundation Trust, London, UK. Dr Gnanasegaran is trained in Nuclear Medicine in London, gaining an MSc and MD from London University, and completing Nuclear Medicine residency from Guy’s & St Thomas’ Hospital, London, UK. He was appointed Consultant in Nuclear Medicine at Guy’s & St Thomas’ Hospital, London in 2007. He was appointed the first education chair of the British Nuclear Medicine Society, UK. He moved to Royal Free Hospital, London, in 2016. He has written and co-edited several books in Nuclear Medicine, including the widely acclaimed Atlas of Clinical Nuclear Medicine 3rd Eds.

Ramin Sadeghi is a Nuclear Medicine specialist and researcher with more than 20 years of experience in the field.
Main field of research of Ramin Sadeghi is sentinel node mapping and lymphoscintigraphy as well as bone mineral densitometry.
Ramin Sadeghi has more than 200 published articles in prestigious journals.

Author of four books and over 100 peer-reviewed papers, Dr. Usmani is a pioneering figure in the field of nuclear medicine and radionuclide therapy. A graduate of the Nuclear Medicine Board of Kuwait and holding an MSc from Islamabad, Pakistan, he has been instrumental in the development of theranostics, SPECT/CT, and PET/CT technology in Kuwait since the late 2000s. As a consultant nuclear medicine physician at the Sultan Qaboos Comprehensive Care and Research Center in Muscat, Oman, Dr. Usmani played a pivotal role in establishing the first theranostic facility in Oman in 2023, offering 177Lu-DOTATATE and 177Lu-PSMA therapies. His pioneering work in Kuwait includes establishing the 177Lu-PSMA therapy in 2014, a groundbreaking treatment targeting prostate-specific membrane antigen (PSMA) that revolutionized advanced prostate cancer management. He further advanced radionuclide therapy by introducing the highly precise 225Ac-PSMA therapy in 2017 and initiating the 177Lu-DOTATATE therapy for neuroendocrine tumors (NET) in 2019. A Fellow of the European Board of Nuclear Medicine (2007), the Asian Nuclear Medicine Board (2018), and the Royal College of Physicians of Edinburgh (2019), Dr. Usmani served as a teaching staff at the Kuwait Institute of Medical Specialization, Oman Medical Specialty Board and holds an Honorary Senior Lecturer position at Hull York Medical School, United Kingdom. He has been recognized with the Outstanding Doctor Award at the Kuwait Cancer Control Center (2016) and the Most Hardworking House Officer Award at the Department of Medicine, Civil Hospital Karachi, Pakistan (2002). Dr. Usmani has served on the editorial boards of numerous cancer research journals and is currently a review editor for Nuclear Medicine at Frontiers in Medicine. His main research interests lie in bone imaging with 18F-NaF PET/CT in non-oncological indications and 68Ga-PSMA imaging in prostate cancer.

Dr. Ghulam Syed is a nuclear physician with 35 years' experience. He did his residency and training at Kings College Hospital London UK. He also obtained a PhD in Medicine from the University of London, UK. He is diplomat Certification Board of nuclear Cardiology, fellow College of Physicians and Surgeons Pakistan and Fellow, Royal College of Physicians, London.
He has worked in the UK, Pakistan, Kuwait, Saudi Arabia and now heads Molecular Imaging Nuclear Medicine Service at HMC Qatar. He has published over 50 papers and 2 book chapters. He is the Fellowship program Director.

Dr Ahmed Aljizeeri is a Consultant in Adult Cardiology & Advanced Cardiac Imaging at King Abdulaziz Cardiac Center, Ministry of National Guard Health Affairs. He received his medical education at King Saud University and completed his postgraduate education in Internal Medicine, Adult Cardiology, Cardiac MRI, Cardiac CT and Nuclear Cardiology at King Abdulaziz Medical City – Riyadh, University of British Columbia, University of Calgary and the University of Ottawa Heart Institute, Canada respectively. Dr Aljizeeri is board certified in Echocardiography, Cardiac CT, Nuclear Cardiology and Cardiac MRI.

Professor and Senior Consultant in Nuclear Medicine, Department of Radiology at King Faisal Specialist Hospital and Research Centre, Kingdom of Saudia Arabia. Had been appointed as the Chairman of Radiology Department for eight (8) years from 2011 until 2019.

Dr. Khalsa Al Nabhani is a senior consultant in Nuclear Medicine and Radiology, currently serving as the Head of the Nuclear Medicine and Molecular Imaging Center at the Royal Hospital in Muscat, Oman. She completed her radiology residency and obtained OMSB and FRCR qualifications in Oman, followed by fellowship training in the UK. Dr. Al-Nabhani also directs the Radiology Residency Training program in Oman for the Oman Medical Specialty Board. Her expertise spans various nuclear medicine practices, with a focus on clinical applications, safety protocols, and advanced imaging techniques. She is actively involved in international collaborations, including ongoing IAEA projects.